SCHEMBL5568086

SCHEMBL5568086

O=C1N(C2CCC(O)CC2)CC[C@@]12CCCN(c1ccc(Br)cn1)C2

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LCAT P04180 1/20 0.38
HSD11B1 P28845 6/20 0.37
CRBN Q96SW2 6/20 0.37
DDB1 Q16531 1/20 0.37
AKR1C3 P42330 1/20 0.36
CXCR3 P49682 1/20 0.36
PIK3CA P42336 1/20 0.35
PDE10A Q9Y233 1/20 0.35
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2A Q12879 1/20 0.34
GRIN2B Q13224 1/20 0.34
GRIN2C Q14957 1/20 0.34
GRIN3A Q8TCU5 1/20 0.34
ADK P55263 1/20 0.33
PANK3 Q9H999 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5930223 1.00 LCAT (0.38) LCATHSD11B1CRBNDDB1AKR1C3
SCHEMBL3705332 1.00 LCAT (0.38) LCATHSD11B1CRBNDDB1AKR1C3
SCHEMBL3705333 1.00 LCAT (0.38) LCATHSD11B1CRBNDDB1AKR1C3
SCHEMBL5629345 0.90 LCAT (0.43) LCATHSD11B1CRBNDDB1AKR1C3
SCHEMBL4720228 0.90 LCAT (0.43) LCATHSD11B1CRBNDDB1AKR1C3
SCHEMBL2700795 0.88 CRBN (0.41) LCATHSD11B1CRBNDDB1PIK3CA
SCHEMBL550340 0.88 CRBN (0.41) LCATHSD11B1CRBNDDB1PIK3CA
SCHEMBL550339 0.88 CRBN (0.41) LCATHSD11B1CRBNDDB1PIK3CA
SCHEMBL549662 0.88 CRBN (0.41) LCATHSD11B1CRBNDDB1PIK3CA
SCHEMBL549661 0.88 CRBN (0.41) LCATHSD11B1CRBNDDB1PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1812005-B1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORP (US) 2015-09-16 EP disclosed
EP-1812005-A2 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS Incyte Corporation (US) 2007-08-01 EP disclosed
US-20060116382-A1 Lactam compounds and their use as pharmaceuticals INCYTE CORPORATION 2006-06-01 US disclosed
WO-2006053024-A2 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2006-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060116382-A1 Lactam compounds and their use as pharmaceuticals HSD11B1, HSD11B2, HSD17B1 LCAT 661/4885HSD11B1 1/4885CRBN 2898/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.